Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
| ▸ | QPCT | Q16769 | 1/20 | 0.41 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.41 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8927292 | 0.80 | TBXAS1 (0.48) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| SCHEMBL7158047 | 0.80 | TBXAS1 (0.48) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL27553888 | 0.79 | TBXAS1 (0.47) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| Styrene SCHEMBL15638667 | 0.77 | TSHR (0.50) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| SCHEMBL28529168 | 0.77 | MAPT (0.55) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| SCHEMBL28118460 | 0.73 | CYP11B1 (0.44) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| SCHEMBL2847392 | 0.72 | ALDH1A1 (0.39) | CYP19A1CYP1A2CYP2D6MAPTMEN1 | |
| SCHEMBL11364719 | 0.71 | MEN1 (0.49) | CYP3A4CYP11B1CYP11B2CYP19A1MAPT | |
| SCHEMBL9586509 | 0.71 | CYP19A1 (0.43) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 | |
| SCHEMBL6002504 | 0.71 | TBXAS1 (0.44) | CYP3A4CYP11B1CYP11B2CYP19A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112191237-B | Preparation and application of porous polyionic liquid compound and method for adsorbing carbon dioxide by using porous polyionic liquid compound | 华侨大学 | 2023-05-30 | — | — | CN | claimed |
| CN-113144816-A | Metal complex ion functionalized polyion liquid and preparation method and application thereof | 华侨大学 | 2021-07-23 | — | — | CN | claimed |
| CN-112191237-A | Preparation and application of porous polyion liquid compound and method for adsorbing carbon dioxide by using porous polyion liquid compound | 华侨大学 | 2021-01-08 | — | — | CN | claimed |
| CN-112191237-B | Preparation and application of porous polyionic liquid compound and method for adsorbing carbon dioxide by using porous polyionic liquid compound | 华侨大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-113144816-A | Metal complex ion functionalized polyion liquid and preparation method and application thereof | 华侨大学 | 2021-07-23 | — | — | CN | disclosed |
| CN-112191237-A | Preparation and application of porous polyion liquid compound and method for adsorbing carbon dioxide by using porous polyion liquid compound | 华侨大学 | 2021-01-08 | — | — | CN | disclosed |
| EP-2367430-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010065152-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | disclosed |
| US-5753682-A | Imidazole lipoxygenase inhibitors | PFIZER INC. (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0703913-B1 | IMIDAZOLES AS LIPOXYGENASE INHIBITORS | PFIZER (US) | 1997-06-11 | — | — | EP | disclosed |